메뉴 건너뛰기




Volumn 143, Issue 40, 1998, Pages 58-69

Comparison of ranitidine preparations;RANITIDINPRAPARATE IM VERGLEICH

Author keywords

[No Author keywords available]

Indexed keywords

AZURANIT; RANI BASF; RANI NERTON; RANI SANORANIA; RANIBERI; RANIBETA; RANIBLOC; RANIMERCK; RANIOUX; RANIPROTECT; RANIPUREN; RANITIC; RANITIDIN ISIS; RANITIDIN RATIOPHARM; RANITIDIN STADA; RANITIDINE; ULCOLIND RANI; UNCLASSIFIED DRUG;

EID: 7844228059     PISSN: 00317136     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (1)

References (5)
  • 3
    • 33748380981 scopus 로고
    • Scrip 1573 (1990),26
    • (1990) Scrip , vol.1573 , pp. 26
  • 4
    • 7844231505 scopus 로고    scopus 로고
    • Glaxo Inc , Ranitidine / Zantac, NDA 18-703, Summary Basis of Approval
    • Glaxo Inc , Ranitidine / Zantac, NDA 18-703, Summary Basis of Approval
  • 5
    • 0031972249 scopus 로고    scopus 로고
    • Comparative bioavailability of two tablet formulations of ranitidine hydrochloride in healthy volunteers
    • Bawazir S.A., et al., Comparative bioavailability of two tablet formulations of ranitidine hydrochloride in healthy volunteers. Int. J. Clin. Pharmacol. Ther. 36, 5 (1998) 270-274.
    • (1998) Int. J. Clin. Pharmacol. Ther. , vol.36 , Issue.5 , pp. 270-274
    • Bawazir, S.A.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.